医学
肾病综合征
蛋白尿
膜性肾病
强的松
肾活检
甲状腺炎
内科学
肾小球肾炎
肾脏疾病
甲状腺过氧化物酶
病理
甲状腺球蛋白
胃肠病学
活检
甲状腺
肾
作者
Precil Diego Miranda de Menezes Neves,Monique Pereira Rêgo Muniz,Giuliano Ferreira Morgantetti,Érico Murilo Monteiro Cutrim,Carlos de Andrade Macieira,Natalino Salgado-Filho,Joyce Santos Lages,Dyego José de Araújo Brito,Kaile de Araújo Cunha,Giuseppe Cesare Gatto,Gyl Eanes Barros Silva
标识
DOI:10.3389/fimmu.2022.824124
摘要
Membranous nephropathy (MN) is a form of kidney disease that is idiopathic in 70%–80% of cases. Glomerular involvement in autoimmune thyroiditis can occur in 10%–30% of patients, and MN manifests in association with Hashimoto thyroiditis in up to 20% of the cases with glomerular involvement. Reports of MN associated with Graves’ disease (GD) are extremely rare in the current literature. Herein, we report the case of a 46-year-old man admitted to the hospital with nephrotic syndrome and symptomatic hyperthyroidism due to GD. Kidney biopsy revealed a secondary MN pattern. Immunohistochemical staining for PLA2R was negative, and thyroglobulin showed weak and segmental staining along the glomerular capillary. Anti-thyroid peroxidase (TPO) antibody test was not performed. The patient was treated for GD with methimazole and prednisone, and despite reaching clinical improvement after 8 months, proteinuria remained close to nephrotic levels. In this scenario, the patient was submitted to radioactive iodine, and there was a dramatic reduction in proteinuria levels after treatment. In conclusion, GD association with MN is rare, and when present, diagnosis using PLA2R and immunohistochemistry can be useful in determining association. In addition, radioactive iodine therapy can be an effective treatment modality when preceded with immunosuppressive corticosteroid therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI